Research

Why Clinical Trial Screening Stalls on Outside Records

By The Arxova Team · October 10, 2026 · 4 min read

Share

The number of data points a single clinical protocol collects has climbed by over 600% since 2005. Every one of those points needs a source, and a large share of the most important ones (prior treatments, comorbidities, historical labs) live outside the site's system, scattered across providers it has no relationship with. Enrollment doesn't slow down because a team is careless. It slows down because assembling a participant's complete medical history was never designed to be one person's job on a fax machine.

Source: IQVIA, 2026

The history that decides eligibility was never on your server

Most eClinical platforms capture data generated during a study: visit data, patient-reported outcomes, protocol labs. They do that well. Most were not built to retrieve the participant's pre-existing records from the outside providers where the actual care happened. That history was never sitting on the site's server.

And that outside history is what determines eligibility. Prior treatments, comorbidities, concomitant medications, historical labs and imaging decide whether a candidate screens in or fails. Until someone retrieves them, they are invisible. A coordinator can spend an afternoon on hold with a hospital records department, only to find the exclusion criterion was sitting in a chart the whole time.

Moving records retrieval to the participant

When the participant connects their own records before screening, the team can see the relevant history up front. That can mean fewer avoidable screen failures, fewer coordinator hours spent on records requests, and a shorter path from consent to enrolled, because history that used to arrive in week three can arrive before day one.

The participant's consent is what makes this work. In Arxova, participants sign the partnering institution's own IRB-approved consent in the app, and only the data they agree to share moves.

Willing to share is not the same as sharing

78.4% vs 26.5%

78.4% of wearable users (1,584 of 2,020 surveyed) say they are willing to share their data with healthcare providers. Only 26.5% actually do.

Source: Journal of Medical Internet Research, 2025

That gap is mostly friction, not reluctance. When sharing takes a few deliberate steps in an app the person already uses, the data has a path to the team that needs it. More on that in why wearable health data isn't reaching your doctor.

Data collected is not data used

~30%

Nearly 30% of the data collected during a typical clinical trial never ends up informing a single decision.

Source: Tufts CSDD & TransCelerate via STAT, 2026

Structured, participant-led history at screening is one way to start shrinking that number: the team collects what the protocol needs, from a source the participant has already assembled.

Running a site, a CRO or a research program?

See how participants bring their own records and wearable data to your study under IRB-approved consent.

Arxova for Research

Arxova is a health data platform and is not a clinical research organization. Participation in research is optional, opt-in and revocable. Arxova does not sell health data and does not pay participants. Clinics and research institutions pay Arxova for the matching infrastructure. Any compensation a study offers is between the participant and the study. Arxova is not a data broker.